Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
Identifieur interne : 001B34 ( Istex/Corpus ); précédent : 001B33; suivant : 001B35Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
Auteurs : S. Kusamura ; B. J. Moran ; P. H. Sugarbaker ; E. A. Levine ; D. Elias ; D. Baratti ; D. L. Morris ; A. Sardi ; O. Glehen ; M. Deraco ; F. N. Gilly ; P. Barrios ; F. Quenet ; B. W. Loggie ; A. G Mez Portilla ; I. H. J. T. De Hingh ; W. P. Ceelen ; J. O. W. Pelz ; P. Piso ; S. González-Moreno ; K. Van Der Speeten ; T. C. Chua ; T. D. Yan ; W. LiauwSource :
- British Journal of Surgery [ 0007-1323 ] ; 2014-12.
Abstract
The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.
Url:
DOI: 10.1002/bjs.9674
Links to Exploration step
ISTEX:903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title><author><name sortKey="Kusamura, S" sort="Kusamura, S" uniqKey="Kusamura S" first="S." last="Kusamura">S. Kusamura</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Moran, B J" sort="Moran, B J" uniqKey="Moran B" first="B. J." last="Moran">B. J. Moran</name><affiliation><mods:affiliation>Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK</mods:affiliation></affiliation></author><author><name sortKey="Sugarbaker, P H" sort="Sugarbaker, P H" uniqKey="Sugarbaker P" first="P. H." last="Sugarbaker">P. H. Sugarbaker</name><affiliation><mods:affiliation>Washington Cancer Institute, Washington Hospital Center, DC, Washington</mods:affiliation></affiliation></author><author><name sortKey="Levine, E A" sort="Levine, E A" uniqKey="Levine E" first="E. A." last="Levine">E. A. Levine</name><affiliation><mods:affiliation>Surgical Oncology Service, Wake Forest University Baptist Medical Center, Winston‐Salem, North Carolina</mods:affiliation></affiliation></author><author><name sortKey="Elias, D" sort="Elias, D" uniqKey="Elias D" first="D." last="Elias">D. Elias</name><affiliation><mods:affiliation>Department of Surgical Oncology, Institut Gustave Roussy, Cancer Centre, Villejuif</mods:affiliation></affiliation><affiliation><mods:affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</mods:affiliation></affiliation></author><author><name sortKey="Baratti, D" sort="Baratti, D" uniqKey="Baratti D" first="D." last="Baratti">D. Baratti</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Morris, D L" sort="Morris, D L" uniqKey="Morris D" first="D. L." last="Morris">D. L. Morris</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author><name sortKey="Sardi, A" sort="Sardi, A" uniqKey="Sardi A" first="A." last="Sardi">A. Sardi</name><affiliation><mods:affiliation>Division of Surgery, Department of Surgical Oncology, Institute for Cancer Care, Mercy Medical Center, Maryland, Baltimore, USA</mods:affiliation></affiliation></author><author><name sortKey="Glehen, O" sort="Glehen, O" uniqKey="Glehen O" first="O." last="Glehen">O. Glehen</name><affiliation><mods:affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Digestive Surgery, CHU de Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France</mods:affiliation></affiliation></author><author><name sortKey="Deraco, M" sort="Deraco, M" uniqKey="Deraco M" first="M." last="Deraco">M. Deraco</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: marcello.deraco@istitutotumori.mi.it</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Gilly, F N" sort="Gilly, F N" uniqKey="Gilly F" first="F. N." last="Gilly">F. N. Gilly</name><affiliation><mods:affiliation>Department of Digestive Surgery, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Hospices Civils de Lyon, and RENAPE, Unité de Recherche Clinique, CHU de Lyon Sud, Pierre‐Benite, France</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Barrios, P" sort="Barrios, P" uniqKey="Barrios P" first="P." last="Barrios">P. Barrios</name><affiliation><mods:affiliation>Department of Oncological Surgery, Hospital Sant Joan Despí, Moises Broggi, Peritoneal Surface Malignancy Catalonian's Programme, Sant Joan Despí, Barcelona, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Quenet, F" sort="Quenet, F" uniqKey="Quenet F" first="F." last="Quenet">F. Quenet</name><affiliation><mods:affiliation>(Centre Régional de Lutte du Cancer Val d'Aurell, Montpellier, and RENAPE, CHU de Lyon Sud, Pierre‐Benite, France</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Loggie, B W" sort="Loggie, B W" uniqKey="Loggie B" first="B. W." last="Loggie">B. W. Loggie</name><affiliation><mods:affiliation>Division of Surgical Oncology, Creighton University Medical Center, Omaha, New England, USA</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="G Mez Portilla, A" sort="G Mez Portilla, A" uniqKey="G Mez Portilla A" first="A." last="G Mez Portilla">A. G Mez Portilla</name><affiliation><mods:affiliation>Department of General Surgery and Digestive Diseases, Hospital Santiago Apostol, Vitoria, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="De Hingh, I H J T" sort="De Hingh, I H J T" uniqKey="De Hingh I" first="I. H. J. T." last="De Hingh">I. H. J. T. De Hingh</name><affiliation><mods:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Ceelen, W P" sort="Ceelen, W P" uniqKey="Ceelen W" first="W. P." last="Ceelen">W. P. Ceelen</name><affiliation><mods:affiliation>Department of Gastrointestinal Surgery, University Hospital, Ghent, Belgium</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Pelz, J O W" sort="Pelz, J O W" uniqKey="Pelz J" first="J. O. W." last="Pelz">J. O. W. Pelz</name><affiliation><mods:affiliation>Department of General, Visceral and Paediatric Surgery, University of Wuerzburg, Wuerzburg, Germany</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Piso, P" sort="Piso, P" uniqKey="Piso P" first="P." last="Piso">P. Piso</name><affiliation><mods:affiliation>Department of Surgery, University Medical Centre Regensburg, Regensburg, Germany</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Gonzalez Oreno, S" sort="Gonzalez Oreno, S" uniqKey="Gonzalez Oreno S" first="S." last="González-Moreno">S. González-Moreno</name><affiliation><mods:affiliation>Peritoneal Surface Oncology Programme, Department of Surgical Oncology, M. D. Anderson Cancer Center Madrid, Madrid, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Van Der Speeten, K" sort="Van Der Speeten, K" uniqKey="Van Der Speeten K" first="K." last="Van Der Speeten">K. Van Der Speeten</name><affiliation><mods:affiliation>Department of Surgical Oncology, Ziekenhuis Oost‐Limburg, Genk, Belgium</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Chua, T C" sort="Chua, T C" uniqKey="Chua T" first="T. C." last="Chua">T. C. Chua</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Yan, T D" sort="Yan, T D" uniqKey="Yan T" first="T. D." last="Yan">T. D. Yan</name><affiliation><mods:affiliation>Department of Cardiothoracic Surgery, University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Liauw, W" sort="Liauw, W" uniqKey="Liauw W" first="W." last="Liauw">W. Liauw</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6</idno><date when="2014" year="2014">2014</date><idno type="doi">10.1002/bjs.9674</idno><idno type="url">https://api.istex.fr/document/903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B34</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B34</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title><author><name sortKey="Kusamura, S" sort="Kusamura, S" uniqKey="Kusamura S" first="S." last="Kusamura">S. Kusamura</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Moran, B J" sort="Moran, B J" uniqKey="Moran B" first="B. J." last="Moran">B. J. Moran</name><affiliation><mods:affiliation>Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK</mods:affiliation></affiliation></author><author><name sortKey="Sugarbaker, P H" sort="Sugarbaker, P H" uniqKey="Sugarbaker P" first="P. H." last="Sugarbaker">P. H. Sugarbaker</name><affiliation><mods:affiliation>Washington Cancer Institute, Washington Hospital Center, DC, Washington</mods:affiliation></affiliation></author><author><name sortKey="Levine, E A" sort="Levine, E A" uniqKey="Levine E" first="E. A." last="Levine">E. A. Levine</name><affiliation><mods:affiliation>Surgical Oncology Service, Wake Forest University Baptist Medical Center, Winston‐Salem, North Carolina</mods:affiliation></affiliation></author><author><name sortKey="Elias, D" sort="Elias, D" uniqKey="Elias D" first="D." last="Elias">D. Elias</name><affiliation><mods:affiliation>Department of Surgical Oncology, Institut Gustave Roussy, Cancer Centre, Villejuif</mods:affiliation></affiliation><affiliation><mods:affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</mods:affiliation></affiliation></author><author><name sortKey="Baratti, D" sort="Baratti, D" uniqKey="Baratti D" first="D." last="Baratti">D. Baratti</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation></author><author><name sortKey="Morris, D L" sort="Morris, D L" uniqKey="Morris D" first="D. L." last="Morris">D. L. Morris</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author><name sortKey="Sardi, A" sort="Sardi, A" uniqKey="Sardi A" first="A." last="Sardi">A. Sardi</name><affiliation><mods:affiliation>Division of Surgery, Department of Surgical Oncology, Institute for Cancer Care, Mercy Medical Center, Maryland, Baltimore, USA</mods:affiliation></affiliation></author><author><name sortKey="Glehen, O" sort="Glehen, O" uniqKey="Glehen O" first="O." last="Glehen">O. Glehen</name><affiliation><mods:affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Digestive Surgery, CHU de Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France</mods:affiliation></affiliation></author><author><name sortKey="Deraco, M" sort="Deraco, M" uniqKey="Deraco M" first="M." last="Deraco">M. Deraco</name><affiliation><mods:affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: marcello.deraco@istitutotumori.mi.it</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Gilly, F N" sort="Gilly, F N" uniqKey="Gilly F" first="F. N." last="Gilly">F. N. Gilly</name><affiliation><mods:affiliation>Department of Digestive Surgery, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Hospices Civils de Lyon, and RENAPE, Unité de Recherche Clinique, CHU de Lyon Sud, Pierre‐Benite, France</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Barrios, P" sort="Barrios, P" uniqKey="Barrios P" first="P." last="Barrios">P. Barrios</name><affiliation><mods:affiliation>Department of Oncological Surgery, Hospital Sant Joan Despí, Moises Broggi, Peritoneal Surface Malignancy Catalonian's Programme, Sant Joan Despí, Barcelona, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Quenet, F" sort="Quenet, F" uniqKey="Quenet F" first="F." last="Quenet">F. Quenet</name><affiliation><mods:affiliation>(Centre Régional de Lutte du Cancer Val d'Aurell, Montpellier, and RENAPE, CHU de Lyon Sud, Pierre‐Benite, France</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Loggie, B W" sort="Loggie, B W" uniqKey="Loggie B" first="B. W." last="Loggie">B. W. Loggie</name><affiliation><mods:affiliation>Division of Surgical Oncology, Creighton University Medical Center, Omaha, New England, USA</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="G Mez Portilla, A" sort="G Mez Portilla, A" uniqKey="G Mez Portilla A" first="A." last="G Mez Portilla">A. G Mez Portilla</name><affiliation><mods:affiliation>Department of General Surgery and Digestive Diseases, Hospital Santiago Apostol, Vitoria, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="De Hingh, I H J T" sort="De Hingh, I H J T" uniqKey="De Hingh I" first="I. H. J. T." last="De Hingh">I. H. J. T. De Hingh</name><affiliation><mods:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Ceelen, W P" sort="Ceelen, W P" uniqKey="Ceelen W" first="W. P." last="Ceelen">W. P. Ceelen</name><affiliation><mods:affiliation>Department of Gastrointestinal Surgery, University Hospital, Ghent, Belgium</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Pelz, J O W" sort="Pelz, J O W" uniqKey="Pelz J" first="J. O. W." last="Pelz">J. O. W. Pelz</name><affiliation><mods:affiliation>Department of General, Visceral and Paediatric Surgery, University of Wuerzburg, Wuerzburg, Germany</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Piso, P" sort="Piso, P" uniqKey="Piso P" first="P." last="Piso">P. Piso</name><affiliation><mods:affiliation>Department of Surgery, University Medical Centre Regensburg, Regensburg, Germany</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Gonzalez Oreno, S" sort="Gonzalez Oreno, S" uniqKey="Gonzalez Oreno S" first="S." last="González-Moreno">S. González-Moreno</name><affiliation><mods:affiliation>Peritoneal Surface Oncology Programme, Department of Surgical Oncology, M. D. Anderson Cancer Center Madrid, Madrid, Spain</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Van Der Speeten, K" sort="Van Der Speeten, K" uniqKey="Van Der Speeten K" first="K." last="Van Der Speeten">K. Van Der Speeten</name><affiliation><mods:affiliation>Department of Surgical Oncology, Ziekenhuis Oost‐Limburg, Genk, Belgium</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Chua, T C" sort="Chua, T C" uniqKey="Chua T" first="T. C." last="Chua">T. C. Chua</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Yan, T D" sort="Yan, T D" uniqKey="Yan T" first="T. D." last="Yan">T. D. Yan</name><affiliation><mods:affiliation>Department of Cardiothoracic Surgery, University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author><author wicri:is="90%"><name sortKey="Liauw, W" sort="Liauw, W" uniqKey="Liauw W" first="W." last="Liauw">W. Liauw</name><affiliation><mods:affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Surgery</title><title level="j" type="alt">BRITISH JOURNAL OF SURGERY</title><idno type="ISSN">0007-1323</idno><idno type="eISSN">1365-2168</idno><imprint><biblScope unit="vol">101</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="1758">1758</biblScope><biblScope unit="page" to="1765">1765</biblScope><biblScope unit="page-count">8</biblScope><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2014-12">2014-12</date></imprint><idno type="ISSN">0007-1323</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-1323</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>S. Kusamura</name><affiliations><json:string>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</json:string></affiliations></json:item><json:item><name>B. J. Moran</name><affiliations><json:string>Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK</json:string></affiliations></json:item><json:item><name>P. H. Sugarbaker</name><affiliations><json:string>Washington Cancer Institute, Washington Hospital Center, DC, Washington</json:string></affiliations></json:item><json:item><name>E. A. Levine</name><affiliations><json:string>Surgical Oncology Service, Wake Forest University Baptist Medical Center, Winston‐Salem, North Carolina</json:string></affiliations></json:item><json:item><name>D. Elias</name><affiliations><json:string>Department of Surgical Oncology, Institut Gustave Roussy, Cancer Centre, Villejuif</json:string><json:string>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</json:string></affiliations></json:item><json:item><name>D. Baratti</name><affiliations><json:string>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</json:string></affiliations></json:item><json:item><name>D. L. Morris</name><affiliations><json:string>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</json:string></affiliations></json:item><json:item><name>A. Sardi</name><affiliations><json:string>Division of Surgery, Department of Surgical Oncology, Institute for Cancer Care, Mercy Medical Center, Maryland, Baltimore, USA</json:string></affiliations></json:item><json:item><name>O. Glehen</name><affiliations><json:string>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</json:string><json:string>Department of Digestive Surgery, CHU de Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France</json:string></affiliations></json:item><json:item><name>M. Deraco</name><affiliations><json:string>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</json:string><json:string>E-mail: marcello.deraco@istitutotumori.mi.it</json:string></affiliations></json:item><json:item><name>F. N. Gilly</name><affiliations><json:string>Department of Digestive Surgery, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Hospices Civils de Lyon, and RENAPE, Unité de Recherche Clinique, CHU de Lyon Sud, Pierre‐Benite, France</json:string></affiliations></json:item><json:item><name>P. Barrios</name><affiliations><json:string>Department of Oncological Surgery, Hospital Sant Joan Despí, Moises Broggi, Peritoneal Surface Malignancy Catalonian's Programme, Sant Joan Despí, Barcelona, Spain</json:string></affiliations></json:item><json:item><name>F. Quenet</name><affiliations><json:string>(Centre Régional de Lutte du Cancer Val d'Aurell, Montpellier, and RENAPE, CHU de Lyon Sud, Pierre‐Benite, France</json:string></affiliations></json:item><json:item><name>B. W. Loggie</name><affiliations><json:string>Division of Surgical Oncology, Creighton University Medical Center, Omaha, New England, USA</json:string></affiliations></json:item><json:item><name>A. Gómez Portilla</name><affiliations><json:string>Department of General Surgery and Digestive Diseases, Hospital Santiago Apostol, Vitoria, Spain</json:string></affiliations></json:item><json:item><name>I. H. J. T. de Hingh</name><affiliations><json:string>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands</json:string></affiliations></json:item><json:item><name>W. P. Ceelen</name><affiliations><json:string>Department of Gastrointestinal Surgery, University Hospital, Ghent, Belgium</json:string></affiliations></json:item><json:item><name>J. O. W. Pelz</name><affiliations><json:string>Department of General, Visceral and Paediatric Surgery, University of Wuerzburg, Wuerzburg, Germany</json:string></affiliations></json:item><json:item><name>P. Piso</name><affiliations><json:string>Department of Surgery, University Medical Centre Regensburg, Regensburg, Germany</json:string></affiliations></json:item><json:item><name>S. González‐Moreno</name><affiliations><json:string>Peritoneal Surface Oncology Programme, Department of Surgical Oncology, M. D. Anderson Cancer Center Madrid, Madrid, Spain</json:string></affiliations></json:item><json:item><name>K. Van Der Speeten</name><affiliations><json:string>Department of Surgical Oncology, Ziekenhuis Oost‐Limburg, Genk, Belgium</json:string></affiliations></json:item><json:item><name>T. C. Chua</name><affiliations><json:string>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</json:string></affiliations></json:item><json:item><name>T. D. Yan</name><affiliations><json:string>Department of Cardiothoracic Surgery, University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia</json:string></affiliations></json:item><json:item><name>W. Liauw</name><affiliations><json:string>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</json:string></affiliations></json:item></author><articleId><json:string>BJS9674</json:string></articleId><arkIstex>ark:/67375/WNG-3K44Z55F-H</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.</abstract><qualityIndicators><refBibsNative>true</refBibsNative><abstractWordCount>30</abstractWordCount><abstractCharCount>252</abstractCharCount><keywordCount>0</keywordCount><score>6.819</score><pdfWordCount>4459</pdfWordCount><pdfCharCount>30215</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>8</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize></qualityIndicators><title>Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title><corporate><json:item><name>Peritoneal Surface Oncology Group International (PSOGI)</name></json:item></corporate><genre><json:string>article</json:string></genre><host><title>British Journal of Surgery</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1365-2168</json:string></doi><issn><json:string>0007-1323</json:string></issn><eissn><json:string>1365-2168</json:string></eissn><publisherId><json:string>BJS</json:string></publisherId><volume>101</volume><issue>13</issue><pages><first>1758</first><last>1765</last><total>8</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Original article</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-3K44Z55F-H</json:string></ark><publicationDate>2014</publicationDate><copyrightDate>2014</copyrightDate><doi><json:string>10.1002/bjs.9674</json:string></doi><id>903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><availability><licence>© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd</licence></availability><date type="published" when="2014-12"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title><author xml:id="author-0000"><persName><forename type="first">S.</forename><surname>Kusamura</surname></persName><affiliation><orgName>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit</orgName><orgName>IRCCS Fondazione Istituto Nazionale Tumori di Milano</orgName><address><settlement type="city">Milan</settlement><country>Italy</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">B. J.</forename><surname>Moran</surname></persName><affiliation><orgName>Basingstoke and North Hampshire NHS Foundation Trust</orgName><address><settlement type="city">Basingstoke</settlement><country>UK</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">P. H.</forename><surname>Sugarbaker</surname></persName><affiliation><orgName>Washington Cancer Institute</orgName><orgName>Washington Hospital Center</orgName><address><settlement type="city">Washington</settlement><region>DC</region></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">E. A.</forename><surname>Levine</surname></persName><affiliation><orgName>Surgical Oncology Service</orgName><orgName>Wake Forest University Baptist Medical Center</orgName><address><settlement type="city">Winston‐Salem</settlement><country>North Carolina</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">D.</forename><surname>Elias</surname></persName><affiliation><orgName>Department of Surgical Oncology</orgName><orgName>Institut Gustave Roussy, Cancer Centre</orgName><address><settlement type="city">Villejuif</settlement></address></affiliation><affiliation><orgName>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine</orgName><orgName>Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud</orgName><address><settlement type="city">Pierre Bénite</settlement><country>France</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">D.</forename><surname>Baratti</surname></persName><affiliation><orgName>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit</orgName><orgName>IRCCS Fondazione Istituto Nazionale Tumori di Milano</orgName><address><settlement type="city">Milan</settlement><country>Italy</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">D. L.</forename><surname>Morris</surname></persName><affiliation><orgName>Hepatobiliary and Surgical Oncology Unit</orgName><orgName>University of New South Wales Department of Surgery, St George Hospital</orgName><address><settlement type="city">New South Wales</settlement><region>Sydney</region><country>Australia</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">A.</forename><surname>Sardi</surname></persName><affiliation><orgName>Division of Surgery, Department of Surgical Oncology</orgName><orgName>Institute for Cancer Care, Mercy Medical Center</orgName><address><settlement type="city">Baltimore</settlement><region>Maryland</region><country>USA</country></address></affiliation></author><author xml:id="author-0008"><persName><forename type="first">O.</forename><surname>Glehen</surname></persName><affiliation><orgName>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine</orgName><orgName>Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud</orgName><address><settlement type="city">Pierre Bénite</settlement><country>France</country></address></affiliation><affiliation><orgName>Department of Digestive Surgery</orgName><orgName>CHU de Lyon Sud, Hospices Civils de Lyon</orgName><address><settlement type="city">Pierre Bénite</settlement><country>France</country></address></affiliation></author><author xml:id="author-0009" role="corresp"><persName><forename type="first">M.</forename><surname>Deraco</surname></persName><affiliation><orgName>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit</orgName><orgName>IRCCS Fondazione Istituto Nazionale Tumori di Milano</orgName><address><settlement type="city">Milan</settlement><country>Italy</country></address></affiliation><affiliation>Correspondence to: Dr M. Deraco, IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, via Venezian 1, 20133 Milan, Italy (e‐mail: marcello.deraco@istitutotumori.mi.it)</affiliation></author><author xml:id="author-0010"><author><orgName>Peritoneal Surface Oncology Group International (PSOGI)</orgName></author></author><idno type="istex">903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6</idno><idno type="ark">ark:/67375/WNG-3K44Z55F-H</idno><idno type="DOI">10.1002/bjs.9674</idno><idno type="unit">BJS9674</idno><idno type="toTypesetVersion">file://BJS.BJS9674.pdf</idno></analytic><monogr><title level="j" type="main">British Journal of Surgery</title><title level="j" type="alt">BRITISH JOURNAL OF SURGERY</title><idno type="pISSN">0007-1323</idno><idno type="eISSN">1365-2168</idno><idno type="book-DOI">10.1002/(ISSN)1365-2168</idno><idno type="book-part-DOI">10.1002/bjs.2014.101.issue-13</idno><idno type="product">BJS</idno><imprint><biblScope unit="vol">101</biblScope><biblScope unit="issue">13</biblScope><biblScope unit="page" from="1758">1758</biblScope><biblScope unit="page" to="1765">1765</biblScope><biblScope unit="page-count">8</biblScope><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2014-12"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract style="main" xml:id="bjs9674-abs-0001">
Background
<p xml:id="bjs9674-para-0001">The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (<hi rend="fc">PMP</hi>) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.</p>
Methods
<p xml:id="bjs9674-para-0002">Data from patients with <hi rend="fc">PMP</hi> treated with the combined procedure across 33 international centres between 1993 and 2012 were analysed retrospectively<hi rend="fi">.</hi> A risk‐adjusted sequential probability ratio test was conducted after defining the target outcome as early oncological failure (disease progression within 2 years of treatment), an acceptable risk for the target outcome (odds ratio) of 2, and type I/<hi rend="fc">II</hi> error rates of 5 per cent. The risk prediction model was elaborated and patients were evaluated sequentially for each centre/surgeon. The learning curve was considered to be overcome and proficiency achieved when the odds ratio for early oncological failure became smaller than 2.</p>
Results
<p xml:id="bjs9674-para-0003">Rates of optimal cytoreduction, severe postoperative morbidity and early oncological failure were 84·4, 25·7 and 29·0 per cent respectively. The median annual centre volume was 17 (range 6–66) peritoneal malignancies. Only eight of the 33 centres and six of 47 surgeons achieved proficiency after a median of 100 (range 78–284) and 96 (86–284) procedures respectively. The most important institutional factor affecting surgical performance was centre volume.</p>
Conclusion
<p xml:id="bjs9674-para-0004">The learning curve is extremely long, so centralization and/or networking of centres is necessary to assure quality of services. One centre for every 10–15 million inhabitants would be ideal.</p></abstract><abstract style="short"><p>One centre for every 10–15 million inhabitants ideal</p></abstract><textClass><keywords rend="articleCategory"><term>Original article</term></keywords><keywords rend="tocHeading1"><term>Original articles</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="bjs9674"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd</publisherName><publisherLoc>Chichester, UK</publisherLoc></publisherInfo><doi>10.1002/(ISSN)1365-2168</doi><issn type="print">0007-1323</issn><issn type="electronic">1365-2168</issn><idGroup><id type="product" value="BJS"></id></idGroup><titleGroup><title type="main" sort="BRITISH JOURNAL OF SURGERY">British Journal of Surgery</title><title type="short">Br J Surg</title></titleGroup></publicationMeta><publicationMeta level="part" position="130"><doi origin="wiley">10.1002/bjs.2014.101.issue-13</doi><copyright ownership="joint">Copyright © 2014 BJS Society Ltd. Published by John Wiley & Sons, Ltd.</copyright><numberingGroup><numbering type="journalVolume" number="101">101</numbering><numbering type="journalIssue">13</numbering></numberingGroup><coverDate startDate="2014-12">December 2014</coverDate></publicationMeta><publicationMeta level="unit" position="160" type="article" status="forIssue"><doi>10.1002/bjs.9674</doi><idGroup><id type="unit" value="BJS9674"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Original article</title><title type="tocHeading1">Original articles</title></titleGroup><copyright ownership="publisher">© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd</copyright><eventGroup><event type="manuscriptReceived" date="2014-01-05"></event><event type="manuscriptRevised" date="2014-08-19"></event><event type="manuscriptAccepted" date="2014-09-17"></event><event type="xmlCreated" agent="Laserwords Private Ltd." date="2014-10-20"></event><event type="publishedOnlineEarlyUnpaginated" date="2014-10-20"></event><event type="firstOnline" date="2014-10-20"></event><event type="publishedOnlineFinalForm" date="2014-11-12"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-06"></event></eventGroup><numberingGroup><numbering type="pageFirst">1758</numbering><numbering type="pageLast">1765</numbering></numberingGroup><correspondenceTo><i>Correspondence to</i>: Dr M. Deraco, IRCCS Fondazione Istituto Nazionale dei Tumori di Milano, via Venezian 1, 20133 Milan, Italy (e‐mail: <email>marcello.deraco@istitutotumori.mi.it</email>)</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file://BJS.BJS9674.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title></titleGroup><creators><creator creatorRole="author" xml:id="bjs9674-cr-0001" affiliationRef="#bjs9674-aff-0001"><personName><givenNames>S.</givenNames>
<familyName>Kusamura</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0002" affiliationRef="#bjs9674-aff-0002"><personName><givenNames>B. J.</givenNames>
<familyName>Moran</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0003" affiliationRef="#bjs9674-aff-0003"><personName><givenNames>P. H.</givenNames>
<familyName>Sugarbaker</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0004" affiliationRef="#bjs9674-aff-0004"><personName><givenNames>E. A.</givenNames>
<familyName>Levine</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0005" affiliationRef="#bjs9674-aff-0006 #bjs9674-aff-0007"><personName><givenNames>D.</givenNames>
<familyName>Elias</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0006" affiliationRef="#bjs9674-aff-0001"><personName><givenNames>D.</givenNames>
<familyName>Baratti</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0007" affiliationRef="#bjs9674-aff-0009"><personName><givenNames>D. L.</givenNames>
<familyName>Morris</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0008" affiliationRef="#bjs9674-aff-0005"><personName><givenNames>A.</givenNames>
<familyName>Sardi</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0009" affiliationRef="#bjs9674-aff-0007 #bjs9674-aff-0008"><personName><givenNames>O.</givenNames>
<familyName>Glehen</familyName></personName></creator><creator creatorRole="author" xml:id="bjs9674-cr-0010" affiliationRef="#bjs9674-aff-0001" corresponding="yes"><personName><givenNames>M.</givenNames>
<familyName>Deraco</familyName></personName></creator>
<creator creatorRole="author" xml:id="bjs9674-cr-0011" noteRef="#bjs9674-note-0001"><groupName xml:id="bjs9674-gp-0001">Peritoneal Surface Oncology Group International (PSOGI)</groupName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1008" affiliationRef="#bjs9674-aff-0101" groupRef="#bjs9674-cr-0011"><personName><givenNames>F. N.</givenNames><familyName>Gilly</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1009" affiliationRef="#bjs9674-aff-0102" groupRef="#bjs9674-cr-0011"><personName><givenNames>P.</givenNames><familyName>Barrios</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1010" affiliationRef="#bjs9674-aff-0103" groupRef="#bjs9674-cr-0011"><personName><givenNames>F.</givenNames><familyName>Quenet</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1011" affiliationRef="#bjs9674-aff-0104" groupRef="#bjs9674-cr-0011"><personName><givenNames>B. W.</givenNames><familyName>Loggie</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1012" affiliationRef="#bjs9674-aff-0105" groupRef="#bjs9674-cr-0011"><personName><givenNames>A.</givenNames><familyName>Gómez Portilla</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1013" affiliationRef="#bjs9674-aff-0106" groupRef="#bjs9674-cr-0011"><personName><givenNames>I. H. J. T.</givenNames><familyName>de Hingh</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1014" affiliationRef="#bjs9674-aff-0107" groupRef="#bjs9674-cr-0011"><personName><givenNames>W. P.</givenNames><familyName>Ceelen</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1015" affiliationRef="#bjs9674-aff-0108" groupRef="#bjs9674-cr-0011"><personName><givenNames>J. O. W.</givenNames><familyName>Pelz</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1016" affiliationRef="#bjs9674-aff-0109" groupRef="#bjs9674-cr-0011"><personName><givenNames>P.</givenNames><familyName>Piso</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1017" affiliationRef="#bjs9674-aff-0110" groupRef="#bjs9674-cr-0011"><personName><givenNames>S.</givenNames><familyName>González‐Moreno</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1018" affiliationRef="#bjs9674-aff-0111" groupRef="#bjs9674-cr-0011"><personName><givenNames>K.</givenNames><familyName>Van Der Speeten</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1019" affiliationRef="#bjs9674-aff-0112" groupRef="#bjs9674-cr-0011"><personName><givenNames>T. C.</givenNames><familyName>Chua</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1020" affiliationRef="#bjs9674-aff-0113" groupRef="#bjs9674-cr-0011"><personName><givenNames>T. D.</givenNames><familyName>Yan</familyName></personName></creator><creator creatorRole="investigator" xml:id="bjs9674-cr-1021" affiliationRef="#bjs9674-aff-0114" groupRef="#bjs9674-cr-0011"><personName><givenNames>W.</givenNames><familyName>Liauw</familyName></personName></creator></creators><affiliationGroup xml:id="bjs9674-affgp-0001"><affiliation xml:id="bjs9674-aff-0001"><orgDiv>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit</orgDiv><orgName>IRCCS Fondazione Istituto Nazionale Tumori di Milano</orgName><address><city>Milan</city><country>Italy</country></address></affiliation><affiliation xml:id="bjs9674-aff-0002"><orgName>Basingstoke and North Hampshire NHS Foundation Trust</orgName><address><city>Basingstoke</city><country>UK</country></address></affiliation><affiliation xml:id="bjs9674-aff-0003"><orgDiv>Washington Cancer Institute</orgDiv><orgName>Washington Hospital Center</orgName><address><city>Washington</city><countryPart>DC</countryPart></address></affiliation><affiliation xml:id="bjs9674-aff-0004"><orgDiv>Surgical Oncology Service</orgDiv><orgName>Wake Forest University Baptist Medical Center</orgName><address><city>Winston‐Salem</city><country>North Carolina</country></address></affiliation><affiliation xml:id="bjs9674-aff-0005"><orgDiv>Division of Surgery, Department of Surgical Oncology</orgDiv><orgName>Institute for Cancer Care, Mercy Medical Center</orgName><address><city>Baltimore</city><countryPart>Maryland</countryPart><country>USA</country></address></affiliation><affiliation xml:id="bjs9674-aff-0006"><orgDiv>Department of Surgical Oncology</orgDiv><orgName>Institut Gustave Roussy, Cancer Centre</orgName><address><city>Villejuif</city></address></affiliation><affiliation xml:id="bjs9674-aff-0007"><orgDiv>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine</orgDiv><orgName>Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud</orgName><address><city>Pierre Bénite</city><country>France</country></address></affiliation><affiliation xml:id="bjs9674-aff-0008"><orgDiv>Department of Digestive Surgery</orgDiv><orgName>CHU de Lyon Sud, Hospices Civils de Lyon</orgName><address><city>Pierre Bénite</city><country>France</country></address></affiliation><affiliation xml:id="bjs9674-aff-0009"><orgDiv>Hepatobiliary and Surgical Oncology Unit</orgDiv><orgName>University of New South Wales Department of Surgery, St George Hospital</orgName><address><city>New South Wales</city><countryPart>Sydney</countryPart><country>Australia</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0101"><orgDiv>Department of Digestive Surgery</orgDiv><orgName>Centre Hospitalier Universitaire (CHU) de Lyon Sud, Hospices Civils de Lyon, and RENAPE, Unité de Recherche Clinique, CHU de Lyon Sud, Pierre‐Benite</orgName><address><country>France</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0102"><orgDiv>Department of Oncological Surgery</orgDiv><orgName>Hospital Sant Joan Despí, Moises Broggi, Peritoneal Surface Malignancy Catalonian's Programme, Sant Joan Despí</orgName><address><city>Barcelona</city><country>Spain</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0103"><orgName>(Centre Régional de Lutte du Cancer Val d'Aurell, Montpellier, and RENAPE, CHU de Lyon Sud, Pierre‐Benite</orgName><address><country>France</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0104"><orgDiv>Division of Surgical Oncology</orgDiv><orgName>Creighton University Medical Center, Omaha, New England</orgName><address><country>USA</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0105"><orgDiv>Department of General Surgery and Digestive Diseases</orgDiv><orgName>Hospital Santiago Apostol</orgName><address><city>Vitoria</city><country>Spain</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0106"><orgDiv>Department of Surgery</orgDiv><orgName>Catharina Hospital, Eindhoven</orgName><address><country>The Netherlands</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0107"><orgDiv>Department of Gastrointestinal Surgery</orgDiv><orgName>University Hospital, Ghent</orgName><address><country>Belgium</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0108"><orgDiv>Department of General</orgDiv><orgName>Visceral and Paediatric Surgery, University of Wuerzburg, Wuerzburg</orgName><address><country>Germany</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0109"><orgDiv>Department of Surgery</orgDiv><orgName>University Medical Centre Regensburg, Regensburg</orgName><address><country>Germany</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0110"><orgDiv>Peritoneal Surface Oncology Programme, Department of Surgical Oncology</orgDiv><orgName>M. D. Anderson Cancer Center Madrid, Madrid</orgName><address><country>Spain</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0111"><orgDiv>Department of Surgical Oncology</orgDiv><orgName>Ziekenhuis Oost‐Limburg, Genk</orgName><address><country>Belgium</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0112"><orgDiv>Hepatobiliary and Surgical Oncology Unit</orgDiv><orgName>University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales</orgName><address><country>Australia</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0113"><orgDiv>Department of Cardiothoracic Surgery</orgDiv><orgName>University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales</orgName><address><country>Australia</country></address></affiliation><affiliation type="organization" xml:id="bjs9674-aff-0114"><orgDiv>Hepatobiliary and Surgical Oncology Unit</orgDiv><orgName>University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales</orgName><address><country>Australia</country></address></affiliation></affiliationGroup><supportingInformation xml:id="bjs9674-supinf-0001"><supportingInfoItem xml:id="bjs9674-supitem-0001"><mediaResource alt="supplementary data" mimeType="application/vnd.openxmlformats-officedocument.wordprocessingml.document" rendition="webOriginal" href="urn-x:wiley:00071323:media:bjs9674:bjs9674-sup-0001-AppendixS1"></mediaResource><caption><b>Appendix S1</b> Statistical analysis (Word document)</caption></supportingInfoItem><supportingInfoItem xml:id="bjs9674-supitem-0002"><mediaResource alt="supplementary data" mimeType="application/vnd.openxmlformats-officedocument.wordprocessingml.document" rendition="webOriginal" href="urn-x:wiley:00071323:media:bjs9674:bjs9674-sup-0002-TableS1"></mediaResource><caption><b>Table S1</b> Characteristics of 33 centres using cytoreductive surgery and intraperitoneal chemotherapy to treat pseudomyxoma peritonei (Word document)</caption></supportingInfoItem><supportingInfoItem xml:id="bjs9674-supitem-0003"><mediaResource alt="supplementary data" mimeType="application/vnd.openxmlformats-officedocument.wordprocessingml.document" rendition="webOriginal" href="urn-x:wiley:00071323:media:bjs9674:bjs9674-sup-0003-TableS2"></mediaResource><caption><b>Table S2</b> Predictors of early oncological failure among 2451 patients with pseudomyxoma peritonei treated with cytoreductive surgery and intraperitoneal chemotherapy (Word document)</caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:id="bjs9674-abs-0001"><section xml:id="bjs9674-sec-0001" numbered="no"><title type="main">Background</title><p xml:id="bjs9674-para-0001">The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (<fc>PMP</fc>) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.</p></section><section xml:id="bjs9674-sec-0002" numbered="no"><title type="main">Methods</title><p xml:id="bjs9674-para-0002">Data from patients with <fc>PMP</fc> treated with the combined procedure across 33 international centres between 1993 and 2012 were analysed retrospectively<fi>.</fi> A risk‐adjusted sequential probability ratio test was conducted after defining the target outcome as early oncological failure (disease progression within 2 years of treatment), an acceptable risk for the target outcome (odds ratio) of 2, and type I/<fc>II</fc> error rates of 5 per cent. The risk prediction model was elaborated and patients were evaluated sequentially for each centre/surgeon. The learning curve was considered to be overcome and proficiency achieved when the odds ratio for early oncological failure became smaller than 2.</p></section><section xml:id="bjs9674-sec-0003" numbered="no"><title type="main">Results</title><p xml:id="bjs9674-para-0003">Rates of optimal cytoreduction, severe postoperative morbidity and early oncological failure were 84·4, 25·7 and 29·0 per cent respectively. The median annual centre volume was 17 (range 6–66) peritoneal malignancies. Only eight of the 33 centres and six of 47 surgeons achieved proficiency after a median of 100 (range 78–284) and 96 (86–284) procedures respectively. The most important institutional factor affecting surgical performance was centre volume.</p></section><section xml:id="bjs9674-sec-0004" numbered="no"><title type="main">Conclusion</title><p xml:id="bjs9674-para-0004">The learning curve is extremely long, so centralization and/or networking of centres is necessary to assure quality of services. One centre for every 10–15 million inhabitants would be ideal.</p></section></abstract><abstract type="short"><p>One centre for every 10–15 million inhabitants ideal</p></abstract></abstractGroup></contentMeta><noteGroup xml:id="bjs9674-ntgp-0001"><note xml:id="bjs9674-note-0001"><p xml:id="bjs9674-para-0005">Members of PSOGI are co‐authors of this study and can be found under the heading Collaborators</p></note><note xml:id="bjs9674-note-0002" numbered="no"><p xml:id="bjs9674-para-0006">Presented to the 66th Society of Surgical Oncology Annual Cancer Symposium, National Harbor, Maryland, USA, February 2013</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Kusamura</namePart><affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B. J.</namePart><namePart type="family">Moran</namePart><affiliation>Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P. H.</namePart><namePart type="family">Sugarbaker</namePart><affiliation>Washington Cancer Institute, Washington Hospital Center, DC, Washington</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E. A.</namePart><namePart type="family">Levine</namePart><affiliation>Surgical Oncology Service, Wake Forest University Baptist Medical Center, Winston‐Salem, North Carolina</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Elias</namePart><affiliation>Department of Surgical Oncology, Institut Gustave Roussy, Cancer Centre, Villejuif</affiliation><affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D.</namePart><namePart type="family">Baratti</namePart><affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D. L.</namePart><namePart type="family">Morris</namePart><affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Sardi</namePart><affiliation>Division of Surgery, Department of Surgical Oncology, Institute for Cancer Care, Mercy Medical Center, Maryland, Baltimore, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Glehen</namePart><affiliation>RENAPE: Centre Expert National de Référence des Cancers Rares du Péritoine, Unité de Recherche Clinique, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Pierre Bénite, France</affiliation><affiliation>Department of Digestive Surgery, CHU de Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Deraco</namePart><affiliation>Peritoneal Surface Malignancy Programme, Colorectal Cancer Unit, IRCCS Fondazione Istituto Nazionale Tumori di Milano, Milan, Italy</affiliation><affiliation>E-mail: marcello.deraco@istitutotumori.mi.it</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="corporate"><namePart>Peritoneal Surface Oncology Group International (PSOGI)</namePart></name><name type="personal"><namePart type="given">F. N.</namePart><namePart type="family">Gilly</namePart><affiliation>Department of Digestive Surgery, Centre Hospitalier Universitaire (CHU) de Lyon Sud, Hospices Civils de Lyon, and RENAPE, Unité de Recherche Clinique, CHU de Lyon Sud, Pierre‐Benite, France</affiliation></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Barrios</namePart><affiliation>Department of Oncological Surgery, Hospital Sant Joan Despí, Moises Broggi, Peritoneal Surface Malignancy Catalonian's Programme, Sant Joan Despí, Barcelona, Spain</affiliation></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Quenet</namePart><affiliation>(Centre Régional de Lutte du Cancer Val d'Aurell, Montpellier, and RENAPE, CHU de Lyon Sud, Pierre‐Benite, France</affiliation></name><name type="personal"><namePart type="given">B. W.</namePart><namePart type="family">Loggie</namePart><affiliation>Division of Surgical Oncology, Creighton University Medical Center, Omaha, New England, USA</affiliation></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Gómez Portilla</namePart><affiliation>Department of General Surgery and Digestive Diseases, Hospital Santiago Apostol, Vitoria, Spain</affiliation></name><name type="personal"><namePart type="given">I. H. J. T.</namePart><namePart type="family">de Hingh</namePart><affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands</affiliation></name><name type="personal"><namePart type="given">W. P.</namePart><namePart type="family">Ceelen</namePart><affiliation>Department of Gastrointestinal Surgery, University Hospital, Ghent, Belgium</affiliation></name><name type="personal"><namePart type="given">J. O. W.</namePart><namePart type="family">Pelz</namePart><affiliation>Department of General, Visceral and Paediatric Surgery, University of Wuerzburg, Wuerzburg, Germany</affiliation></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Piso</namePart><affiliation>Department of Surgery, University Medical Centre Regensburg, Regensburg, Germany</affiliation></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">González‐Moreno</namePart><affiliation>Peritoneal Surface Oncology Programme, Department of Surgical Oncology, M. D. Anderson Cancer Center Madrid, Madrid, Spain</affiliation></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Van Der Speeten</namePart><affiliation>Department of Surgical Oncology, Ziekenhuis Oost‐Limburg, Genk, Belgium</affiliation></name><name type="personal"><namePart type="given">T. C.</namePart><namePart type="family">Chua</namePart><affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</affiliation></name><name type="personal"><namePart type="given">T. D.</namePart><namePart type="family">Yan</namePart><affiliation>Department of Cardiothoracic Surgery, University of Sydney, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia</affiliation></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Liauw</namePart><affiliation>Hepatobiliary and Surgical Oncology Unit, University of New South Wales Department of Surgery, St George Hospital, Sydney, New South Wales, Australia</affiliation></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>John Wiley & Sons, Ltd</publisher><place><placeTerm type="text">Chichester, UK</placeTerm></place><dateIssued encoding="w3cdtf">2014-12</dateIssued><dateCreated encoding="w3cdtf">2014-10-20</dateCreated><dateCaptured encoding="w3cdtf">2014-01-05</dateCaptured><dateValid encoding="w3cdtf">2014-09-17</dateValid><copyrightDate encoding="w3cdtf">2014</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>The learning curves for cytoreductive surgery with intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei (PMP) were explored between international centres/surgeons to identify institutional or other factors that might affect performance.</abstract><abstract>Data from patients with PMP treated with the combined procedure across 33 international centres between 1993 and 2012 were analysed retrospectively. A risk‐adjusted sequential probability ratio test was conducted after defining the target outcome as early oncological failure (disease progression within 2 years of treatment), an acceptable risk for the target outcome (odds ratio) of 2, and type I/II error rates of 5 per cent. The risk prediction model was elaborated and patients were evaluated sequentially for each centre/surgeon. The learning curve was considered to be overcome and proficiency achieved when the odds ratio for early oncological failure became smaller than 2.</abstract><abstract>Rates of optimal cytoreduction, severe postoperative morbidity and early oncological failure were 84·4, 25·7 and 29·0 per cent respectively. The median annual centre volume was 17 (range 6–66) peritoneal malignancies. Only eight of the 33 centres and six of 47 surgeons achieved proficiency after a median of 100 (range 78–284) and 96 (86–284) procedures respectively. The most important institutional factor affecting surgical performance was centre volume.</abstract><abstract>The learning curve is extremely long, so centralization and/or networking of centres is necessary to assure quality of services. One centre for every 10–15 million inhabitants would be ideal.</abstract><abstract type="short">One centre for every 10–15 million inhabitants ideal</abstract><note type="additional physical form">Appendix S1 Statistical analysis (Word document)Table S1 Characteristics of 33 centres using cytoreductive surgery and intraperitoneal chemotherapy to treat pseudomyxoma peritonei (Word document)Table S2 Predictors of early oncological failure among 2451 patients with pseudomyxoma peritonei treated with cytoreductive surgery and intraperitoneal chemotherapy (Word document)</note><relatedItem type="host"><titleInfo><title>British Journal of Surgery</title></titleInfo><titleInfo type="abbreviated"><title>Br J Surg</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Original article</topic></subject><identifier type="ISSN">0007-1323</identifier><identifier type="eISSN">1365-2168</identifier><identifier type="DOI">10.1002/(ISSN)1365-2168</identifier><identifier type="PublisherID">BJS</identifier><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><detail type="issue"><caption>no.</caption><number>13</number></detail><extent unit="pages"><start>1758</start><end>1765</end><total>8</total></extent></part></relatedItem><identifier type="istex">903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6</identifier><identifier type="ark">ark:/67375/WNG-3K44Z55F-H</identifier><identifier type="DOI">10.1002/bjs.9674</identifier><identifier type="ArticleID">BJS9674</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2014 BJS Society Ltd. Published by John Wiley & Sons, Ltd.© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>John Wiley & Sons, Ltd</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6/metadata/json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001B34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:903FA5A4B9B92907CB7C2DCAB2B998F26737ADC6
|texte= Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
}}
| This area was generated with Dilib version V0.6.33. |  |